DK0832886T3 - Flavon-derivater, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende derivaterne - Google Patents
Flavon-derivater, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende derivaterneInfo
- Publication number
- DK0832886T3 DK0832886T3 DK97402202T DK97402202T DK0832886T3 DK 0832886 T3 DK0832886 T3 DK 0832886T3 DK 97402202 T DK97402202 T DK 97402202T DK 97402202 T DK97402202 T DK 97402202T DK 0832886 T3 DK0832886 T3 DK 0832886T3
- Authority
- DK
- Denmark
- Prior art keywords
- alkyl
- optionally substituted
- derivatives
- alkoxy
- optionally
- Prior art date
Links
- 150000002212 flavone derivatives Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 125000001072 heteroaryl group Chemical group 0.000 abstract 3
- 239000004215 Carbon black (E152) Substances 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- 229930195733 hydrocarbon Natural products 0.000 abstract 2
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 2
- MUQNGPZZQDCDFT-JNQJZLCISA-N Halcinonide Chemical group C1CC2=CC(=O)CC[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@@H]2O MUQNGPZZQDCDFT-JNQJZLCISA-N 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 229940028332 halog Drugs 0.000 abstract 1
- 150000002430 hydrocarbons Chemical class 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- 125000001041 indolyl group Chemical group 0.000 abstract 1
- 125000005956 isoquinolyl group Chemical group 0.000 abstract 1
- 125000001786 isothiazolyl group Chemical group 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 125000002971 oxazolyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- -1 polycyclic hydrocarbon Chemical class 0.000 abstract 1
- 125000003373 pyrazinyl group Chemical group 0.000 abstract 1
- 125000003226 pyrazolyl group Chemical group 0.000 abstract 1
- 125000002098 pyridazinyl group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 125000000168 pyrrolyl group Chemical group 0.000 abstract 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 abstract 1
- 125000005493 quinolyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000335 thiazolyl group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9611808A FR2753969B1 (fr) | 1996-09-27 | 1996-09-27 | Nouveaux derives de flavones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0832886T3 true DK0832886T3 (da) | 2003-03-10 |
Family
ID=9496129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97402202T DK0832886T3 (da) | 1996-09-27 | 1997-09-23 | Flavon-derivater, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende derivaterne |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5889003A (da) |
| EP (1) | EP0832886B1 (da) |
| JP (1) | JPH10114766A (da) |
| CN (1) | CN1094936C (da) |
| AT (1) | ATE227712T1 (da) |
| AU (1) | AU728990B2 (da) |
| BR (1) | BR9704900A (da) |
| CA (1) | CA2216617C (da) |
| DE (1) | DE69717044T2 (da) |
| DK (1) | DK0832886T3 (da) |
| ES (1) | ES2187738T3 (da) |
| FR (1) | FR2753969B1 (da) |
| HU (1) | HUP9701588A3 (da) |
| NO (1) | NO974455L (da) |
| NZ (1) | NZ328858A (da) |
| PL (1) | PL322297A1 (da) |
| PT (1) | PT832886E (da) |
| ZA (1) | ZA978652B (da) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2231509C (en) * | 1995-09-11 | 2008-07-08 | Osteoarthritis Sciences, Inc. | Protein tyrosine kinase inhibitors for treating osteoarthritis |
| CA2341488A1 (en) | 1998-08-26 | 2000-03-09 | Smithkline Beecham Corporation | Therapies for treating pulmonary diseases |
| WO2000017184A1 (en) * | 1998-09-24 | 2000-03-30 | Mitsubishi Chemical Corporation | Hydroxyflavone derivatives as tau protein kinase 1 inhibitors |
| PL200923B1 (pl) | 1999-08-21 | 2009-02-27 | Nycomed Gmbh | Lek zawierający inhibitor PDE w połączeniu z agonistą receptoraß₂ -adrenergicznego oraz zastosowanie połączenia roflumilastu i salmeterolu |
| US6806257B1 (en) | 1999-10-20 | 2004-10-19 | Board Of Trustees Of Southern Illinois University | Flavones as inducible nitric oxide synthase inhibitors, cyclooxygenase-2 inhibitors and potassium channel activators |
| US6334998B1 (en) | 1999-12-07 | 2002-01-01 | Parker Hughes Institute | Estrogens for treating ALS |
| EP1127572A3 (en) * | 2000-02-25 | 2003-05-02 | Basf Aktiengesellschaft | Use of flavones for treating cycloxygenase-2 mediated diseases |
| US6472436B1 (en) * | 2000-07-17 | 2002-10-29 | The Salk Institute For Biological Studies | Methods for protecting cells from amyloid toxicity and for inhibiting amyloid protein production |
| DE10104350A1 (de) | 2001-02-01 | 2002-08-14 | Merck Patent Gmbh | Verfahren zur Herstellung von Flavon Derivaten |
| DE10232595A1 (de) * | 2002-07-18 | 2004-02-05 | Merck Patent Gmbh | Lichtschutzmittel |
| JP2006522151A (ja) | 2003-04-01 | 2006-09-28 | アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ | 不妊症におけるホスホジエステラーゼ阻害剤 |
| JP5058481B2 (ja) * | 2005-11-28 | 2012-10-24 | 丸善製薬株式会社 | 角化細胞増殖剤、サイクリックampホスホジエステラーゼ阻害剤、及び保湿剤 |
| US20100056791A1 (en) * | 2006-09-01 | 2010-03-04 | Yasushi Kohno | Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor containing the same |
| CN101148444A (zh) * | 2006-09-20 | 2008-03-26 | 上海特化医药科技有限公司 | 黄酮衍生物、制备方法及应用 |
| KR100930467B1 (ko) * | 2007-06-07 | 2009-12-08 | 동아제약주식회사 | 점액분비를 촉진시키는 3',4',5-트리메톡시 플라본 유도체화합물, 그의 제조방법 및 약학적 용도 |
| JP4559531B1 (ja) * | 2009-12-03 | 2010-10-06 | ウシオケミックス株式会社 | ノビレチンの製造方法 |
| CN103059005B (zh) * | 2012-11-22 | 2015-04-22 | 中南民族大学 | 白杨素酰胺衍生物及其医药用途 |
| CN105906598B (zh) * | 2016-05-19 | 2018-05-08 | 江苏耐雀生物工程技术有限公司 | 白杨素衍生物及其制备方法和应用 |
| WO2026068627A1 (en) | 2024-09-25 | 2026-04-02 | Institut Gustave Roussy | Flavonoid derivatives compounds, and their use as drugs |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2623808B1 (fr) * | 1987-12-01 | 1990-03-09 | Adir | Nouveaux derives flavonoides (benzyl-4 piperazinyl-1)-2 oxo-2 ethylene substitues, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2689127B1 (fr) * | 1992-03-31 | 1994-05-06 | Adir Cie | Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
| FR2748025B1 (fr) * | 1996-04-25 | 1998-10-30 | Adir | Nouveaux acides et esters de la diosmetine, et les compositions pharmaceutiques les contenant |
-
1996
- 1996-09-27 FR FR9611808A patent/FR2753969B1/fr not_active Expired - Fee Related
-
1997
- 1997-09-23 AT AT97402202T patent/ATE227712T1/de not_active IP Right Cessation
- 1997-09-23 DK DK97402202T patent/DK0832886T3/da active
- 1997-09-23 DE DE69717044T patent/DE69717044T2/de not_active Expired - Fee Related
- 1997-09-23 EP EP97402202A patent/EP0832886B1/fr not_active Expired - Lifetime
- 1997-09-23 PT PT97402202T patent/PT832886E/pt unknown
- 1997-09-23 ES ES97402202T patent/ES2187738T3/es not_active Expired - Lifetime
- 1997-09-25 PL PL97322297A patent/PL322297A1/xx unknown
- 1997-09-26 HU HU9701588A patent/HUP9701588A3/hu unknown
- 1997-09-26 BR BR9704900A patent/BR9704900A/pt not_active IP Right Cessation
- 1997-09-26 CN CN97120535A patent/CN1094936C/zh not_active Expired - Fee Related
- 1997-09-26 NZ NZ328858A patent/NZ328858A/en unknown
- 1997-09-26 NO NO974455A patent/NO974455L/no not_active Application Discontinuation
- 1997-09-26 US US08/968,837 patent/US5889003A/en not_active Expired - Fee Related
- 1997-09-26 AU AU39271/97A patent/AU728990B2/en not_active Ceased
- 1997-09-26 ZA ZA9708652A patent/ZA978652B/xx unknown
- 1997-09-26 JP JP9261323A patent/JPH10114766A/ja active Pending
- 1997-09-26 CA CA002216617A patent/CA2216617C/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2187738T3 (es) | 2003-06-16 |
| CN1179422A (zh) | 1998-04-22 |
| DE69717044D1 (de) | 2002-12-19 |
| EP0832886A1 (fr) | 1998-04-01 |
| NO974455D0 (no) | 1997-09-26 |
| AU728990B2 (en) | 2001-01-25 |
| DE69717044T2 (de) | 2003-07-24 |
| US5889003A (en) | 1999-03-30 |
| AU3927197A (en) | 1998-04-02 |
| HUP9701588A3 (en) | 1999-03-01 |
| ZA978652B (en) | 1998-03-27 |
| CN1094936C (zh) | 2002-11-27 |
| BR9704900A (pt) | 1998-10-27 |
| HU9701588D0 (en) | 1997-11-28 |
| FR2753969B1 (fr) | 1998-10-30 |
| NZ328858A (en) | 1998-01-26 |
| ATE227712T1 (de) | 2002-11-15 |
| FR2753969A1 (fr) | 1998-04-03 |
| EP0832886B1 (fr) | 2002-11-13 |
| NO974455L (no) | 1998-03-30 |
| HUP9701588A2 (hu) | 1998-12-28 |
| JPH10114766A (ja) | 1998-05-06 |
| PL322297A1 (en) | 1998-03-30 |
| CA2216617A1 (fr) | 1998-03-27 |
| PT832886E (pt) | 2003-03-31 |
| CA2216617C (fr) | 2002-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA978652B (en) | Flavone compounds, process for preparing them and pharmaceutical compositions containing them. | |
| PT652868E (pt) | Inibidores da fosfodiesterase do amp ciclico | |
| DK0576350T3 (da) | Forgrenede alkylaminothiazolderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem | |
| DE69918404D1 (de) | Aminophenoxyessigsäure derivate als neuroschützende mittel | |
| AU677868B2 (en) | New naphthalene derivatives, processes for their preparation and the pharmaceutical compositions which contain them | |
| NO179975C (no) | Analogifremgangsmåte for fremstilling av heterocykliske derivater | |
| BR9908764A (pt) | Composto e seus sais farmaceuticamente aceitáveis ou ésteres hidrolisáveis in vivo, uso destes, processo para prepará-los, e, composição farmacêutica | |
| FR2599740B1 (fr) | Derives de benzo(b)thiophene de benzo(b)furannecarboxamides, leurs procedes de preparation et les medicaments les contenant | |
| DK0630366T3 (da) | Substituerede heterocycliske derivater, der er nyttige som blodpladeaggregeringsinhibitorer | |
| TR200103349T2 (tr) | Purin türevleri, hazırlama usulü ve bunları içeren ispençiyari bileşimleri. | |
| ES2172294T3 (es) | Nuevos derivados del 1-indanol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2106439T3 (es) | 5-(piperazinilalquil)-1,5-benzotiazepinonas utiles como antagonistas de calcio. | |
| SE7712733L (sv) | Substituerade o-fenylendiaminderivat, sett for framstellning samt anvendning derav som lekemedel | |
| DK185984D0 (da) | Disubstituerede polymethyleniminer,fremgangsmaader til deres fremstilling og farmaceutiske kompositioner indeholdende dem | |
| DE59606328D1 (de) | Verfahren zur Herstellung von gegebenenfalls 2-substituierten 5-Chlor-imidazol-4-carbaldehyden | |
| ES454285A1 (es) | Procedimiento para preparar derivados de 4-amina trans-deca-hidroquinolina. | |
| ES2192827T3 (es) | Derivados de 8h-(2,3-b)-pirrolicin-8-ona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| YU53392A (sh) | Supstituisani 3-aminohinuklidini | |
| TH97636B (th) | อนุพันธุ์เบนไซซาซีนและการใช้สารเหล่านี้ |